newsfilter
← Latest News
GlobeNewswire·

ProMIS Neurosciences to Participate in H.C. Wainwright BioConnect 2022 Virtual Conference

TORONTO, Ontario and CAMBRIDGE, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX:PMN) (OTCQB:ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as